CHROMID? CPS? ELITE AGAR 418284

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-03-02 for CHROMID? CPS? ELITE AGAR 418284 manufactured by Biom?rieux S.a..

Event Text Entries

[68772130] A customer in (b)(6) reported the occurrence of no growth when testing multiple patients' samples for urine culture while using the chromid? Cps? Elite agar. The customer mentioned that they had proceeded with the subculture of the patients' strains' in macconkey agar and that they could formerly identify the colonies as proteus and escherichia coli using additional tests. No further detail was provided. The customer said that they had observed the same issue with the previous batch of cpse reference 418284. In mitigation of the lack of growth observed by the customer, the device instruction for use - limitation of the method states growth depends on the requirements of each individual microorganism. It is, therefore, possible that certain strains which have specific requirements (substrate, temperature, incubation conditions, etc. ) may not develop on the medium. The customer stated that no biased results were reported to a physician and that the patients concerned had not been harmed as a result of the reported events. There is no indication or report from the hospital or treating physician to biom? Rieux that the occurrence led to any adverse event related to a patient's state of health. There may be a potential for adverse event if the event were to reoccur; therefore, this event is being reported as a malfunction. Culture submittal has been requested from the customer by biom? Rieux for internal investigation. Biom? Rieux internal investigation has been initiated.
Patient Sequence No: 1, Text Type: D, B5


[74515782] A customer in (b)(4 reported the occurrence of no growth when testing multiple patients' samples for urine culture while using the chromid? Cps? Elite agar. The strains and plates were not available from the customer for evaluation. An investigation was performed. The quality control strains tested were: e. Coli atcc 25922. E. Coli 9909604. Klebsiella pneumoniae atcc 13883. Proteus mirabilis atcc 12453. Enterococcus faecalis atcc 29212. After inoculation of retained samples of the chromid? Cps? Elite agar batch, and incubation for 18-24 hours, the sensitivity of identifying the e. Coli and proteeae strains according to the color and morphology of the colonies, was excellent. The e. Coli strains produced the expected colony appearance by developing a spontaneous red to burgundy color, and producing beta-glucuronidase ( beta-gur) and/ or beta-galactosidase ( beta-gur). The proteus strain produced a spontaneous diffused brown color, and produced deaminase. The klebsiella strain produced the expected colony appearance by developing a spontaneous blue to green color and producing beta-glucosidase ( beta-glu). The enterococcus strain produced the expected colony appearance by developing a spontaneous turqouse color and producing beta-glucosidase ( beta-glu). In summary, the findings were expected and within the acceptance criteria for quality control. A review of quality records confirmed the lot of chromid? Cps? Elite agar conformed to manufacturing specifications and final release criteria. The investigation concluded the customer issue is not related to the performance of the chromid? Cps? Elite agar. The investigation findings are equivalent to the released batch. All strains were recovered at 18-24 hours and the enzymatic reactions were as the ones expected, and did produce a false negative reaction on the batch. The problem could be linked with clinical sample management and/or inoculation. This medium is very sensitive to temperature, although stability data supports thermal shock is related to order preparation and customer distribution, any deviation linked with storage could explain the loose of sensitivity. However, this could not be confirmed without the customer's agar plates. The package insert has the limitation: growth depends on the requirements of each individual microorganism. It is therefore possible that certain strains which have specific requirements (substrate, temperature, incubation conditions, etc. ) may not develop on the medium, although is very strange that 2 do not grow at the same time without the customer strains or agar plates, further investigation is not possible.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2017-00040
MDR Report Key6371534
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-03-02
Date of Report2017-04-20
Date Mfgr Received2017-03-23
Date Added to Maude2017-03-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. ELLEN WELTMER
Manufacturer Street595 ANGLUM ROAD
Manufacturer CitySAINT LOUIS MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer G1BIOM
Manufacturer Street5, RUE DES AQUEDUCS CRAPONNE, FR 69290
Manufacturer CountryFR
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCHROMID? CPS? ELITE AGAR
Generic NameCHROMID? CPS? ELITE AGAR
Product CodeJXA
Date Received2017-03-02
Catalog Number418284
Lot Number1005333320
Device Expiration Date2017-03-27
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOM?RIEUX S.A.
Manufacturer Address5, RUE DES AQUEDUCS CRAPONNE, FR 69290 FR


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.